{'fraction_non_alphanumeric': 0.01800327332242226, 'fraction_numerical': 0.0, 'mean_word_length': 5.375, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Insulin and value-added therapy

Insulin therapy too is acknowledged as an essential aspect of diabetes management, with unquestionable benefits. In spite of great strides in the manufacture, presentation and quality of this molecule, however, we have not achieved commensurable improvement in glycemic control. Data from across the world reports sub optimal control of persons started on insulin therapy. The best of randomized controlled trials and observational studies are unable to achieve target glycemic levels in all enrolled subjects. This happens in spite of aggressive treat to-target protocols used.